Explore the complete record of transactions filed by QUANTITATIS SARL, Gérant de QUANTITATIS SARL. Insider active across 1 company, notably Plant Advanced Technologies PAT. Aggregated, 1 reports have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €9k. History available since 15 December 2025. The latest transaction was filed on 15 December 2025 (Cession). Regulator: AMF. All data is accessible without signup.
1 of 1 declaration
QUANTITATIS SARL is a French holding company closely connected to the shareholding structure of Plant Advanced Technologies PAT (PAT), a company listed on Euronext Growth. In PAT’s governance framework, QUANTITATIS functions as a patrimonial and investment-holding vehicle used to organize ownership, manage participations, and support the financial structure surrounding the group and its related interests. PAT’s published documents indicate that Jean-Paul FEVRE has served as manager of QUANTITATIS since November 29, 2022, while Thierry FEVRE held that position until November 28, 2022. Within the PAT ecosystem, Jean-Paul FEVRE plays a central role. He is also Chairman and Chief Executive Officer of Plant Advanced Technologies PAT, a company specialized in the discovery and eco-friendly production of hard-to-source plant-based biomolecules. The available information shows that he combines operational leadership at PAT with a patrimonial oversight role through QUANTITATIS, which points to an integrated approach to strategy, capital allocation, and corporate governance. QUANTITATIS is described as a holding company whose core purpose is to acquire and hold equity interests, manage securities, and oversee treasury and internal financing arrangements. Its legal and corporate updates confirm its role as a control and ownership-consolidation structure around PAT. Stock-market and regulatory publications have also linked QUANTITATIS to patrimonial reorganization work and to share transactions involving PAT, reinforcing its profile as a long-term shareholder governance vehicle. From an expertise standpoint, the relationship between QUANTITATIS and PAT reflects a strong command of listed-company governance, capital structure design, family and shareholder alignment, and strategic oversight in plant biotechnology. Overall, the profile suggests a leader focused on value creation, shareholding stability, and continuity in strategic execution.